Literature DB >> 25439299

Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.

A de A Tamega1, H A Miot, N P Moço, M G Silva, M E A Marques, L D B Miot.   

Abstract

OBJECTIVE: Compare gene and protein expression for oestrogen receptor-β (ER-β) and progesterone receptor (PR) in facial melasma and adjacent healthy skin.
METHODS: A cross-sectional study including 42 women with facial melasma, conducted at the Dermatology Service of Botucatu Medical School of São Paulo State University, Brazil. Biopsies of the melasma skin were performed, together with healthy surrounding skin. The gene expression (real-time PCR) of the hormone receptors in the tissue was evaluated. Subsequently, skin fragments were immunostained for nuclear ER-β and PR, evaluated according to their HSCORE (epidermis) and percentage of staining per microscopic field (dermis).
RESULTS: Messenger RNA tissue expression for ER-β and PR showed no difference between melasma-affected skin fragments and the healthy perilesional areas (P > 0.2). Median nuclear epithelial expression for ER-β and PR was higher in lesioned skin (HSCORE 157 and 58) than in the healthy perilesional skin (HSCORE 97 and 19; P < 0.01), with no difference in dermal immunostaining. Nuclear histological expression for ER-β was associated to sun-induced melasma and negative familiar background; PR expression was associated to sun-induced melasma and darker phototypes.
CONCLUSION: No difference was observed in gene expression for oestrogen-β and progesterone receptors in melasma-affected skin compared with adjacent healthy skin. However, the higher protein expression of these receptors in melasma-affected epithelia suggests hormonal participation in the pathogenesis of this disease.
© 2014 Society of Cosmetic Scientists and the Société Française de Cosmétologie.

Entities:  

Keywords:  immunohistochemistry; melanin; melanocytes; melanogenesis; melasma; oestrogen receptor-β; pigmentation; progesterone receptor

Mesh:

Substances:

Year:  2014        PMID: 25439299     DOI: 10.1111/ics.12186

Source DB:  PubMed          Journal:  Int J Cosmet Sci        ISSN: 0142-5463            Impact factor:   2.970


  6 in total

1.  Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.

Authors:  Emerson V A Lima; Mariana Modesto D A Lima; Mauricio Pedreira Paixão; Hélio Amante Miot
Journal:  BMC Dermatol       Date:  2017-11-28

2.  Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments.

Authors:  Dorina Coricovac; Claudia Farcas; Cristian Nica; Iulia Pinzaru; Sebastian Simu; Dana Stoian; Codruta Soica; Maria Proks; Stefana Avram; Dan Navolan; Catalin Dumitru; Ramona Amina Popovici; Cristina Adriana Dehelean
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

Review 3.  Update on Melasma-Part I: Pathogenesis.

Authors:  Ana Cláudia C Espósito; Daniel P Cassiano; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Ediléia Bagatin; Luciane D B Miot; Hélio Amante Miot
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29

4.  Fibroblast morphology, growth rate and gene expression in facial melasma.

Authors:  Ana Cláudia Cavalcante Espósito; Gabrielli Brianezi; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-07-12       Impact factor: 2.113

Review 5.  Melasma: an Up-to-Date Comprehensive Review.

Authors:  Oluwatobi A Ogbechie-Godec; Nada Elbuluk
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-19

6.  Profile of dermatological consultations in Brazil (2018).

Authors:  Hélio Amante Miot; Gerson de Oliveira Penna; Andréa Machado Coelho Ramos; Maria Lúcia Fernandes Penna; Sílvia Maria Schmidt; Flávio Barbosa Luz; Maria Auxiliadora Jeunon Sousa; Sérgio Luiz Lira Palma; José Antonio Sanches Junior
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.